“milgamma® Mono 150
With vitamin B1 deficiency
Milgamma® Mono 150 contains vitamin B1 for the nerve cells. The unique active ingredient Benfotiamine, a variant of the vitamin B1, is absorbed 5 times better by the body than conventional vitamin B1. For the treatment and prophylaxis of vitamin B1 deficiency states.”
MILGAMMA Mono 150 covered tablets, 60 pcs
€0.00
“milgamma® Mono 150.
Active ingredient: Benfotiamine 150 mg.
Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, provided that they cannot be remedied; Treatment of neuropathies and cardiovascula. Sturgeon., D. can be caused by vitamin B1 deficiency.
Read the package supplement and ask your doctor or pharmacist for risks and side effects.”
Out of stock
SKU:
Demaindiab104
Categories: Diabetes, Immune system
Brand: Wörwag Pharma GmbH & Co. KG
Brands: Wörwag Pharma GmbH & Co. KG
Description
Additional information
Reviews (0)
Be the first to review “MILGAMMA Mono 150 covered tablets, 60 pcs” Cancel reply
You must be logged in to post a review.
Shipping & Delivery
Related products
BD Micro-Fine Ultra Pen Needles 0.25×8 mm, 100 pcs
€34.00
OPSITE IV 3000 6×7 cm Trans. Channel fixing, 100 pcs
€205.00
Opsite IV3000 is a transparent association for the cannula and catheter fixation. It consists of a thin polyurethane membrane that is coated with a hypoallergenic glue. The polyurethane membrane is the patented Reactic® film. This film with its special molecular structure reacts quickly to the appearance of moisture and derives it as water vapor.
NOVOFINE 6 mm cannula 32 g TIP ETW, 100 pcs
€31.00
"Novofine® 6 mm 32 g TIP
Is a 0.25 mm injection needle with a 0.23 mm needle tip, a conical shape and a polished surface.
Novofine® 32 g TIP ETC is also equipped with the ""Thin-Wall"" technology (TW = thin-walled needles).
This means that the inner diameter has been enlarged, but the outside diameter of the needle has remained the same. Injections can be carried out faster and less pressure when using these needles."

Reviews
There are no reviews yet.